Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal β-glucuronidase activity

[1]  H. Iwasaki,et al.  The Inhibitory Effect of Ciprofloxacin on the β‐Glucuronidase‐mediated Deconjugation of the Irinotecan Metabolite SN‐38‐G , 2016, Basic & clinical pharmacology & toxicology.

[2]  P. Xu,et al.  Paroxetine decreased plasma exposure of glyburide partly via inhibiting intestinal absorption in rats. , 2015, Drug metabolism and pharmacokinetics.

[3]  M. Surette,et al.  NSAID enteropathy and bacteria: a complicated relationship , 2015, Journal of Gastroenterology.

[4]  S. Masuda,et al.  Inhibitory effect of ciprofloxacin on β‐glucuronidase‐mediated deconjugation of mycophenolic acid glucuronide , 2014, Biopharmaceutics & drug disposition.

[5]  M. Redinbo,et al.  Bacterial β-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics , 2014, Xenobiotica; the fate of foreign compounds in biological systems.

[6]  P. Xu,et al.  Identification of the metabolites of anti-inflammatory compound clematichinenoside AR in rat intestinal microflora. , 2013, Biomedical chromatography : BMC.

[7]  J. Wallace.  Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy. , 2013, World journal of gastroenterology.

[8]  M. Redinbo,et al.  Multiple NSAID-induced hits injure the small intestine: underlying mechanisms and novel strategies. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[9]  Qiong Zhou,et al.  A novel local recycling mechanism that enhances enteric bioavailability of flavonoids and prolongs their residence time in the gut. , 2012, Molecular pharmaceutics.

[10]  Xiao-dong Liu,et al.  Pharmacokinetic-pharmacodynamic modeling of diclofenac in normal and Freund's complete adjuvant-induced arthritic rats , 2012, Acta Pharmacologica Sinica.

[11]  M. Redinbo,et al.  Pharmacologic Targeting of Bacterial β-Glucuronidase Alleviates Nonsteroidal Anti-Inflammatory Drug-Induced Enteropathy in Mice , 2012, Journal of Pharmacology and Experimental Therapeutics.

[12]  U. Boelsterli,et al.  Pharmacologic targeting or genetic deletion of mitochondrial cyclophilin D protects from NSAID-induced small intestinal ulceration in mice. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  T. Gan,et al.  Diclofenac: an update on its mechanism of action and safety profile , 2010, Current medical research and opinion.

[14]  M. Neag,et al.  Pharmacokinetic interaction between zolpidem and ciprofloxacin in healthy volunteers , 2010, European Journal of Drug Metabolism and Pharmacokinetics.

[15]  U. Boelsterli,et al.  Protection from diclofenac-induced small intestinal injury by the JNK inhibitor SP600125 in a mouse model of NSAID-associated enteropathy. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[16]  M. Danhof,et al.  Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats , 2008, British journal of pharmacology.

[17]  K. Vukovinsky,et al.  Comparison of the gravimetric, phenol red, and 14C-PEG-3350 methods to determine water absorption in the rat single-pass intestinal perfusion model , 2001, AAPS PharmSci.

[18]  Arif O. Khan.  Bilateral inverse globe retraction (Duane′s) syndrome , 2007, Indian journal of ophthalmology.

[19]  H. Khan,et al.  Topical diclofenac versus dexamethasone after strabismus surgery: a double-blind randomized clinical trial of anti-inflammatory effect and ocular hypertensive response. , 2007, Indian journal of ophthalmology.

[20]  R. Borrows,et al.  The Magnitude and Time Course of Changes in Mycophenolic Acid 12-Hour Predose Levels During Antibiotic Therapy in Mycophenolate Mofetil-Based Renal Transplantation , 2007, Therapeutic drug monitoring.

[21]  M. Dündar,et al.  Can the Effect of Antibiotherapy and Anti-Inflammatory Therapy on Serum PSA Levels Discriminate between Benign and Malign Prostatic Pathologies? , 2006, Urologia Internationalis.

[22]  R. Borrows,et al.  Determinants of Mycophenolic Acid Levels After Renal Transplantation , 2005, Therapeutic drug monitoring.

[23]  F. Torres-Molina,et al.  Pharmacokinetics and bioavailability of diclofenac in the rat , 1991, Journal of Pharmacokinetics and Biopharmaceutics.

[24]  P. Neuvonen,et al.  Ciprofloxacin greatly increases concentrations and cypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2–mediated presystemic metabolism , 2004, Clinical pharmacology and therapeutics.

[25]  K. Tabata,et al.  Evaluation of Intestinal Absorption into the Portal System in Enterohepatic Circulation by Measuring the Difference in Portal–Venous Blood Concentrations of Diclofenac , 1995, Pharmaceutical Research.

[26]  E. Kalso,et al.  Methadone, ciprofloxacin, and adverse drug reactions , 2000, The Lancet.

[27]  A. West,et al.  Drug enterocyte adducts: possible causal factor for diclofenac enteropathy in rats. , 2000, Gastroenterology.

[28]  P. Neuvonen,et al.  Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia , 2000, European Journal of Clinical Pharmacology.

[29]  P. Bernstein,et al.  Exophiala werneckii endophthalmitis following cartaract surgery in an immunocompetent individual. , 2000, Ophthalmic surgery and lasers.

[30]  M. Zhu,et al.  Influence of Sanguisorba officinalis, a mineral-rich plant drug, on the pharmacokinetics of ciprofloxacin in the rat. , 1999, The Journal of antimicrobial chemotherapy.

[31]  U. Boelsterli,et al.  Diclofenac acyl glucuronide, a major biliary metabolite, is directly involved in small intestinal injury in rats. , 1998, Gastroenterology.

[32]  F. López-Muñoz,et al.  Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of diclofenac in the rat. , 1997, The Journal of pharmacology and experimental therapeutics.

[33]  N. Davies,et al.  Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation. , 1997, Gastroenterology.

[34]  M. Monshouwer,et al.  Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[35]  Y. El‐Sayed,et al.  Effect of famotidine on ciprofloxacin pharmacokinetics after single intravenous and oral doses in rats , 1994, Journal of clinical pharmacy and therapeutics.

[36]  K. Yamaoka,et al.  A new analysis method for disposition kinetics of enterohepatic circulation of diclofenac in rats. , 1994, Drug metabolism and disposition: the biological fate of chemicals.

[37]  A. Macpherson,et al.  Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. , 1993, Gastroenterology.

[38]  U. Fuhr,et al.  Effects of Temafloxacin and Ciprofloxacin on the Pharmacokinetics of Caffeine , 1992, Clinical pharmacokinetics.

[39]  J. Lettieri,et al.  Impact of ciprofloxacin on theophylline clearance and steady-state concentrations in serum , 1988, Antimicrobial Agents and Chemotherapy.

[40]  Jerome J. Schentag,et al.  Effect of multiple dose oral ciprofloxacin on the pharmacokinetics of theophylline and indocyanine green. , 1987, The Journal of antimicrobial chemotherapy.

[41]  R. Kato,et al.  Disposition and enterohepatic circulation of diclofenac in dogs. , 1980, Arzneimittel-Forschung.

[42]  B. Drasar,et al.  Intestinal bacteria and the hydrolysis of glycosidic bonds. , 1971, Journal of medical microbiology.

[43]  Intestinal Bacteria , 1903, The Hospital.